Financials
Income statement
Fiscal date | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|---|
Total reported revenue | 85.4B | 85.8B | 67.4B | 65.8B |
Cost of revenue | 59.0B | 59.2B | 47.0B | 46.2B |
Gross profit | 26.4B | 26.7B | 20.4B | 19.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 15.6B | 15.1B | 11.2B | 10.1B |
Other operating expenses | — | — | — | — |
Operating income | 10.8B | 11.5B | 9.2B | 9.4B |
Non operating interest income | ||||
Income | 550.1M | 581.7M | 580.8M | 338.7M |
Expense | 2.1B | 2.1B | 1.6B | 1.6B |
Other income expense | — | — | — | — |
Pretax income | 10.1B | 11.2B | 9.6B | 9.4B |
Tax provision | 2.1B | 2.1B | 1.5B | 1.3B |
Net income | 8.1B | 7.9B | 8.2B | 8.1B |
Basic EPS | 0.3 | 0.3 | 0.3 | 0.3 |
Diluted EPS | 0.3 | 0.3 | 0.3 | 0.3 |
Basic average shares | 25.1B | 25.1B | 628.2B | 635.3B |
Diluted average shares | 25.1B | 25.1B | 628.4B | 635.3B |
EBITDA | 12.2B | 13.3B | 11.3B | 11.0B |
Net income from continuing op. | — | — | — | — |
Minority interests | -1.3B | -904.5M | -816.6M | -938.5M |
Preferred stock dividends | 0 | 0 | 0 | 0 |